Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, Marksans Pharma has informed that as per information received by the undersigned from BSE, CFC Finlease, a SEBI Licensed ESG Rating Provider (ERP), has voluntarily reviewed the ESG rating on the Company, based on data available in public domain for the Fiscal 2025, and assigned an ESG Score of ‘73’. The same can be accessed at https://www.bseindia.com/stock-share-price/marksans-pharmaltd/marksans/524404/intermediaries-ERP/.
The above information is a part of company’s filings submitted to BSE.
